Asahi Kasei to buy Swedish drugmaker Calliditas for $1.1 billion

Japan's Asahi Kasei
said on Tuesday it offered to acquire Calliditas Therapeutics
for about 11.8 billion Swedish crowns
as part of a plan to become a global drug company.
The Japanese...

Related Keywords

Japan ,United States ,Tokyo ,Sweden ,American ,Japanese ,Swedish ,Muralikumar Anantharaman ,Asahi Kasei ,Reuters ,Calliditas Therapeutics ,Stockholm Based Calliditas ,Rocky Swift ,